Literature DB >> 8337372

Tumor imaging and therapy.

A M Scott1, S M Larson.   

Abstract

Oncology applications in nuclear medicine include both the staging of tumors, e.g., bone scanning, and monitoring response to therapy with tumor-specific radionuclides such as 67Ga-citrate and 201Tl-chloride. An increasing role for positron emission tomography and monoclonal antibody studies in oncology is emerging, and therapeutic applications in thyroid cancer and in the treatment of metastatic bone pain are achieving impressive results. This area is likely to become the fastest growing component of nuclear medicine practice over the next decade.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8337372

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  5 in total

1.  2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses.

Authors:  Rakesh Kumar; Anil Chauhan; Paras Lakhani; Yan Xiu; Hongming Zhuang; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

Review 2.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

3.  Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models.

Authors:  Julie K Jang; Leslie A Khawli; Ryan Park; Brian W Wu; Zibo Li; David Canter; Peter S Conti; Alan L Epstein
Journal:  Mol Cancer Ther       Date:  2013-10-15       Impact factor: 6.261

4.  Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody.

Authors:  Rushika M Perera; Roberto Zoncu; Terrance G Johns; Marc Pypaert; Fook-Thean Lee; Ira Mellman; Lloyd J Old; Derek K Toomre; Andrew M Scott
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

5.  The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease.

Authors:  Justus-Martijn Brinkman; Johannes L Bron; Paul Ijm Wuisman; Paul J van Diest; Emile Fi Comans; Carla Fm Molthoff
Journal:  World J Surg Oncol       Date:  2007-11-12       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.